{
    "clinical_study": {
        "@rank": "156250", 
        "arm_group": [
            {
                "arm_group_label": "sugar pill", 
                "arm_group_type": "Placebo Comparator"
            }, 
            {
                "arm_group_label": "Antioxidantia", 
                "arm_group_type": "Active Comparator", 
                "description": "Dosage: 600mg n-acetylcystein and 200mg magnesium intake: 1 hour before leisure noise exposure above 100dB of at least 30 minutes frequency: 4 separate events (2x placebo, 2x antioxidants)"
            }
        ], 
        "brief_summary": {
            "textblock": "The current study is a dubble-blinde placebo-controlled cross-over study verifying the\n      preventive effect of antioxidants on noise-induced hearing loss (NIHL) and noise-induced\n      tinnitus (NIT). The antioxidants comprise of a mixture of magnesium and n-acetylcystein\n      which should be taken 1h before leisure noise above 100dB for at least 30 minutes."
        }, 
        "brief_title": "Prevention of Noise-induced Damage by Use of Antioxidants", 
        "condition": [
            "Noise-induced Tinnitus", 
            "Noise-induced Hearing Loss"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Hearing Loss", 
                "Deafness", 
                "Hearing Loss, Noise-Induced", 
                "Tinnitus"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age: 18-25 years old\n\n          -  Temporary tinnitus after noise exposure: loudness >5 on a VAS\n\n        Exclusion Criteria:\n\n          -  middle ear problems\n\n          -  Allergy for magnesium or n-acetylcystein\n\n          -  Use of hearing protection when going out"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "25 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 28, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01727492", 
            "org_study_id": "12/18/172"
        }, 
        "intervention": {
            "arm_group_label": "Antioxidantia", 
            "intervention_name": "Antioxidantia", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Antioxidants"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "prevention", 
            "noise-induced tinnitus", 
            "noise-induced hearing loss", 
            "young population"
        ], 
        "lastchanged_date": "November 5, 2013", 
        "location": {
            "contact": {
                "email": "annick.gilles@uza.be", 
                "last_name": "Annick Gilles, Master", 
                "phone": "32 821 32 57"
            }, 
            "facility": {
                "address": {
                    "city": "Antwerp", 
                    "country": "Belgium", 
                    "state": "Edegem", 
                    "zip": "2650"
                }, 
                "name": "Antwerp University Hospital"
            }, 
            "investigator": {
                "last_name": "Annick Gilles, Master", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Belgium"
        }, 
        "number_of_arms": "2", 
        "other_outcome": {
            "description": "A limited number of participants will have audiological testing (audiometry including high frequency audiometry, speech-in-noise testing and otoacoustic emissions) prior to the musical event as well as the morning after noise exposure in order to measure the effects of antioxidants on the hearing thresholds and hearing performance.", 
            "measure": "Decrease of temporary threshold shift in antioxidant trials compared to placebo trials"
        }, 
        "overall_contact": {
            "email": "annick.gilles@uza.be", 
            "last_name": "Annick Gilles, Master", 
            "phone": "32 3 821 52 80"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Belgium: Ethics Committee"
        }, 
        "phase": "N/A", 
        "primary_outcome": {
            "description": "Antioxidants protect against temporary threshold shift. The most prevalent cause of noise-induced tinnitus is noise-induced hearing loss. Therefore, it is assumed that the preventive intake of antioxidants prior to a loud event, might protect against threshold shift as well as noise-induced tinnitus.\nA 50% decrease of tinnitus loudness scored on a Visual Analogue Scale (VAS) compared to placebo trials is expected.", 
            "measure": "Protection against noise-induced tinnitus due to antioxidants"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01727492"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University Hospital, Antwerp", 
            "investigator_full_name": "Ethisch Comit\u00e9 UZ Antwerpen", 
            "investigator_title": "Ethics Comittee UZ Antwerpen", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "It is expected that with the intake of antioxidants noise-induced tinnitus is prevented or reduced after loud music exposure. In addition, it is expected that the tinnitus persistence is shortened compared to the placebo arm.", 
            "measure": "Change of tinnitus duration"
        }, 
        "source": "University Hospital, Antwerp", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Antwerp", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}